# NICE - National Institute for Health and Care Excellence

This provider exposes tools and data accessible through its parent verticals. Use the example prompts as inspiration for your queries.

**Slug:** `nice`

**Description:** NICE (England) health technology assessment: technology appraisal and highly specialised technology recommendations per indication (recommended, optimised, not recommended, Cancer Drugs Fund), plus live search of all NICE guidance including appraisals in development.

## Verticals

This provider is available in the following verticals:

- [Medical](https://kirha.com/verticals/medical.md)

## Example prompts (non-exhaustive)

- `Is pembrolizumab recommended by NICE for non-small-cell lung cancer?`
- `Which NICE technology appraisals published since September 2026 were not recommended?`
- `Which drugs are currently funded through the Cancer Drugs Fund?`
- `Which NICE appraisals of bladder cancer drugs are in development and when are they expected?`

## Available tools in this provider

Open a tool to see its input and output schemas.

### [`searchNiceTechnologyAppraisals`](https://kirha.com/providers/nice/searchNiceTechnologyAppraisals.md)

Search NICE (England) technology appraisal (TA) and highly specialised technology (HST) decisions by technology/INN, indication, recommendation outcome, guidance id and date. Returns one row per appraised indication with NICE's recommendation (recommended, optimised = recommended for a narrower population, notRecommended, onlyInResearch, terminated = no company submission), Cancer Drugs Fund flags and the recommendation wording. Rows without a recommendation are HST guidance or TAs published after NICE's last monthly data-file update: open the url. Use searchNiceGuidance for appraisals in development and other NICE guidance.

### [`searchNiceGuidance`](https://kirha.com/providers/nice/searchNiceGuidance.md)

Live search of all NICE (England) guidance by keyword, programme and status: technology appraisals (including those in development with their expected publication date, terminated or awaiting development), highly specialised technologies, NICE guidelines, interventional procedures, diagnostics and HealthTech guidance. Returns guidance ids, status and dates, not recommendation outcomes: use searchNiceTechnologyAppraisals for the TA recommendation per indication.

-----

**Tags:** health, uk, hta, market access, medication, regulatory

[< Back to providers list](https://kirha.com/providers.md)